|Articles|March 1, 2017
- Pharmaceutical Executive-03-01-2017
- Volume 37
- Issue 3
Pharmaceutical Executive, March 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Big Data: Is It Crunch Time for Pharma?about 9 years ago
Setting Sights on the Smart Supply Chainover 9 years ago
Global Pharma Deals with US Trade Overhaulsover 9 years ago
Precision Medicine and Big Dataover 9 years ago
Country Report: IrelandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5